Radboudumc spin-off Thirona just closed a financing round with Belgian investment fund HERAN Partners, and Borski Fund from the Netherlands. The proceeds of the financing round will be allocated to accelerate the company’s transition towards market leadership in medical imaging.
Now that Thirona is closing in on 10 million images analyzed and Thirona’s solutions have been validated in over 180 scientific publications, they are looking to expand operations and scale up development efforts. As a company, Thirona has always placed a high emphasis on research and development. This has enabled them to establish strong academic, clinical, and industrial partnerships. Now, Thirona find themselves at a tipping point in their journey, expediting their international expansion and development goals. They are pleased to have found the right partners in HERAN Partners and Borski Fund to help accelerate their growth trajectory.
Related news items
Aftermovie Investment Day 2022 and a new date for 2023!13 December 2022
Over 100 scientists, investors, and entrepreneurs came together to accelerate innovation in healthcare by creating new business opportunities and forging strong public-private partnerships.read more
Aiosyn selected as finalist for OostNL's Startversneller vote now!18 October 2022
The 6 finalists of the election “Starter with impact Eastern Netherlands 2022” have been announced and Radboudumc’s Aiosyn is one of them.read more
Successful matchmaking at Radboudumc Investment Day7 October 2022
On the 5th of October, over 100 scientists, investors and entrepreneurs came together at the second Radboudumc Investment Day, jointly hosted by Radboudumc, Oost NL and Briskr.read more
Aiosyn and Radboudumc are the first in the Netherlands to implement AI in the clinical pathology workflow Digital pathology slides will be screened with a quality control algorithm4 April 2022 Aiosyn, a company that develops AI-powered computational pathology analysis for clinical diagnostics, and the department of pathology of Radboudumc, will collaborate to implement an algorithm for quality control of digitized histopathology tissue slides. read more
Thomas van den Heuvel wins Stairway to Impact Award for safer pregnancies using AI Award for safer pregnancies using AI1 December 2021
Radboudumc researcher Thomas van den Heuvel receives the Stairway to Impact Award from Dutch Research Council NWO. He receives this prize for the development of the BabyChecker, a smartphone application that allows midwives to make ultrasounds during pregnancies.read more